Anticancer agent 54
Anticancer agent 54 is a potent anticancer agent. Anticancer agent 54 shows antiproliferative activity. Anticancer agent 54 induces apoptosis and cell cycle arrest at G0/G1 phases. Anticancer agent 54 shows anticancer activity depends on DNA intercalation and ROS generation.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2933882-99-4
- 分子式: C33H36N6
- 分子量:516.68
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.75 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
|
[PMID: 31962262] |
| HCT-116 | IC50 |
0.27 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human HCT 116 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
Antiproliferative activity against human HCT 116 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
|
[PMID: 31962262] |
| MCF7 | IC50 |
0.039 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of CuSO4 by MTS assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of CuSO4 by MTS assay
|
[PMID: 31962262] |
| MCF7 | IC50 |
0.04 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
|
[PMID: 31962262] |
| MCF7 | IC50 |
1 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of CdSO4 by MTS assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of CdSO4 by MTS assay
|
[PMID: 31962262] |
| MCF7 | IC50 |
1 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of FeCl3 by MTS assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of FeCl3 by MTS assay
|
[PMID: 31962262] |
| MCF7 | IC50 |
1 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of FeSO4 by MTS assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of FeSO4 by MTS assay
|
[PMID: 31962262] |
| MCF7 | IC50 |
1 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of ZnCl2 by MTS assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability measured after 72 hrs in presence of ZnCl2 by MTS assay
|
[PMID: 31962262] |
| NHDF | IC50 |
20.83 μM
Compound: Table 1, R1C1
|
Cytotoxicity against human NHDF cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
Cytotoxicity against human NHDF cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
|
[PMID: 31962262] |
| PANC-1 | IC50 |
0.44 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human PANC-1 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
Antiproliferative activity against human PANC-1 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
|
[PMID: 31962262] |
| U-251 | IC50 |
0.14 μM
Compound: Table 1, R1C1
|
Antiproliferative activity against human U251 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
Antiproliferative activity against human U251 cells assessed as reduction in cell viability measured after 72 hrs by MTS assay
|
[PMID: 31962262] |
体外実験
Anticancer agent 54 (compound L) (0-25 µM; 72 h) shows antiproliferative activity with IC50s of 0.04, 0.44, 0.27, 0.14, 0.75, 20.83 µM for MCF-7, PANC-1, HCT116, U-251, A549, NHDF (normal human fifibroblast) clls, respectively[1].
Anticancer agent 54 (1, 2.5, 5 µM; 24 h) induces cell cycle arrest at G0/G1 phases and apoptosis in a concentration-dependent manner[1].
Anticancer agent 54 (1 µM; 24 h) increases the reactive oxygen species (ROS) level[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 cells
-
Concentration:1, 2.5, 5 µM
-
Incubation Time:24 h
-
Result:Induced cell cycle arrest at G0/G1 phases in a concentration-dependent manner.
-
Cell Line:MCF-7 cells
-
Concentration:1, 2.5, 5 µM
-
Incubation Time:24 h
-
Result:The level of the apoptotic cells increased from 7.62% to 29.33% and the population of living cells decreased from 92.01% to 55.27% at 5 µM.
- Detection of Apoptosis
- TUNEL staining for apoptotic DNA fragmentation
- Flow cytometric DNA-content cell-cycle staining
- Annexin V plus membrane-impermeant dye apoptosis staining
- BrdU Incorporation Assay
- ROS/oxidative-stress fluorescent staining
- Apoptosis Solutions
- Protocol for Cell Cycle
- Cell Viability Determination by MTT Colorimetric Assay
化学情報
-
CAS 番号 2933882-99-4
-
分子量 516.68
-
分子式 C33H36N6
-
SMILES
CCCCCCCCCCN1C=C(N=N1)C2=CC=C(C=C2)C3=CC(C4=NC=CC=C4)=NC(C5=CC=CC=N5)=C3
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)